Brief: Vista Pharmaceuticals Signs A Non-Disclosure Agreement To Buy Complex ANDA For Urocare
29/05/2018 06:07
May 29 (Reuters) - Vista Pharmaceuticals Ltd VIPH.BO :
* SAYS CO SIGNED A NON-DISCLOSURE AGREEMENT TO ACQUIRE A
COMPLEX
ANDA FOR UROCARE
* SAYS ANDA WILL BE MANUFACTURED AT ANOTHER US FDA APPROVED
CONTRACT MANUFACTURING FACILITY (CMO) FOR 2 YEARS
Source text - http://bit.ly/2LCDPx3
Further company coverage: VIPH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vista Pharmaceuticals
See all newsBrief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
Brief: Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
Brief: Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
Brief: Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman